Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Liu, M.D.

Concepts (170)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with David Liu's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that David Liu has written about over time.
Carcinoma, Transitional Cell, 1 publications between 2016 and 2016, average publication date July 2016. Carcinoma, 1 publications between 2017 and 2017, average publication date December 2017. Urinary Bladder, 1 publications between 2017 and 2017, average publication date December 2017. Urinary Bladder Neoplasms, 4 publications between 2016 and 2020, average publication date June 2018. Xeroderma Pigmentosum Group D Protein, 3 publications between 2016 and 2020, average publication date August 2018. Antineoplastic Combined Chemotherapy Protocols, 6 publications between 2016 and 2021, average publication date August 2018. Tumor Escape, 2 publications between 2018 and 2019, average publication date December 2018. DNA Mismatch Repair, 2 publications between 2018 and 2019, average publication date January 2019. Drug Resistance, Neoplasm, 12 publications between 2017 and 2021, average publication date January 2020. Skin Neoplasms, 3 publications between 2019 and 2020, average publication date February 2020. Melanoma, 6 publications between 2018 and 2022, average publication date May 2020. Nerve Tissue Proteins, 1 publications between 2021 and 2021, average publication date May 2021. Receptors, Nerve Growth Factor, 1 publications between 2021 and 2021, average publication date May 2021.

To see the data from this visualization as text, click here.
Liu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (170)
Explore
_
Co-Authors (115)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.